When I am asked by a CEO to invest, the first question I ask is how much of your own money have you invested, and will be investing alongside your shareholders. If the answer is nothing, I generally pass on the investment based upon the simple premise that if the head of the company does not believe enough to invest his own money, something is amiss.
I violated this cardinal rule in the case of Cytodyn based upon what I believe to be its compelling science. However. I did so in spite of my concerns with the CEO who I believe to be underqualified,
overcompensated. and not committed enough to invest one cent of his own money in all the years he has been paid an exorbitant salary.
Market Data 
Markets 
AI
